Percutaneous coronary intervention for acute myocardial infarction in a pediatric patient with coronary aneurysm and stenosis due to Kawasaki disease.
We report the case of an acutely ill 3-year-old female, with a previous medical history of Kawasaki disease, who presented to care with an acute myocardial infarction. We describe the coordinated therapies employed by pediatric and adult cardiologists aimed to establish coronary revascularization.
Emory University School of Medicine, Atlanta, GA 30322, USA. ddrossn@emory.edu
David M
DM
Drossner
Clay
C
Chappell
Tanveer
T
Rab
Dennis
D
Kim
D000800:Angioplasty, Balloon; D000925:Anticoagulants / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D006328:Cardiac Catheterization; D003323:Coronary Aneurysm / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy*; D017023:Coronary Angiography; D023921:Coronary Stenosis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy*; D054855:Drug-Eluting Stents; D004562:Electrocardiography; D000068338:Everolimus; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007223:Infant; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications* / Q000000981:diagnostic imaging / Q000628:therapy*; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy*; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*
D000925:Anticoagulants; D015415:Biomarkers; D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus